Ann C.

I am a highly motivated and collaborative self-starter with extensive experience as an oncology trial operations leader. My strong trial management skills encompass strategic clinical trial planning, data review, effective communication with principal investigators, and authoring protocol and regulatory documents. I served as the global clinical trial manager for a pivotal phase 2 trial in metastatic colorectal cancer (mCRC), which led to the first FDA approval for HER2+ mCRC. My previous industry experience includes leadership roles in patient-facing clinical settings for multiple systemic autoimmune disease trials and progressive growth in trial operations for a CRO. I mentored and trained field monitors while managing sites with complex clinical, organizational, and quality issues. My excellence in driving cross-functional collaboration earned me a place as a hand-picked, foundational member of an early oncology pipeline start-up team for a multinational biopharma company. Currently, as a senior trial manager, I lead a global study team with multiple vendors (central lab, imaging, tissue, PROs, qualitative interviewing, and subject reimbursement) in a competitive recruitment landscape for a leading oncology molecule in NSCLC for Seagen/Pfizer. I am an innovative, curious, and results-driven individual with strong analytical, research, and communication skills. I am known as an emotionally intelligent leader, problem solver, and project remediator. My focus every day is driven by operational excellence in targeted oncology drug development for people living with cancer.